Campral · DIN 02293269 · 333 mg · DR tablet
Limited Use, Reason for Use code 531 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 531 required
Write on scriptReason for Use code 531 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 531
Reason for Use code 531
For the treatment of alcohol use disorder in patients who:
- Meet clinical criteria for alcohol use disorder; and
- Express a commitment to abstain from alcohol; and
- Have been abstinent from alcohol for at least 3 days prior to starting acamprosate; and
- Have confirmed participation in counselling and treatment for alcohol use disorder*
* An individualized treatment plan will have one or more of the following components: Counselling and follow-up with the patient's family physician, addiction physician, or psychiatrist; self-help groups such as Alcoholics Anonymous; and outpatient, day, or inpatient psychosocial rehabilitation programs.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Campral · DIN 02293269
Manufacturer: Mylan Pharmaceuticals ULC; listing date 2018-06-29
Health Canada: Marketed since 2010-05-28 · brand CAMPRAL · ATC N07BB03 ACAMPROSATE · form Tablet (delayed-release) · route Oral · ingredients ACAMPROSATE CALCIUM 333 MG · company Mylan pharmaceuticals ulc · schedule Prescription
Campral: Formulary list price $1.02 per unit (the source does not state the unit; exact figure $1.0195). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02293269)
Source record
DIN 02293269: Campral
Raw flags: sec12=Y, sec3=Y
Item: 289200029; group id 533; item number 1442; lccId 00305; manufacturer id MYL
Source form: DR Tab; strength: 333mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $1.0195; ministry $1.0195
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02293269
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77863
Shortage status: resolved shortage (ended December 24, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02293269
Shortage record checked October 6, 2026